TOC
Home > Transfer

Technology transfer at the DRFZ

From concept to application

Technology transfer enables companies and external partners to access innovations and findings developed at the DRFZ. Our expertise lies in identifying new therapeutic targets, diagnostic methods and biomarkers for diagnosis, treatment response and disease progression. We utilise state-of-the-art technologies, which are constantly being further developed. To ensure these processes are effective and to bridge the gap between research and application, the DRFZ collaborates with large clinical partners including Charité, as well as with partners from the biotech and pharmaceutical industries. Beyond that, we can refer to a large network of other research institutes within the Leibniz Association.

Externally, the DRFZ also cooperates with Ascenion GmbH, a knowledge and technology transfer company specialising in the life sciences, to commercialise its intellectual property.

If you are interested in collaboration, please feel free to contact us.

Contact

DRFZ Spin-outs

Targeting plasma cells in autoimmunity
Novel therapeutics targeting immunometabolic reprogramming in inflammation
Label-free technology and single-cell fingerprints for diagnostics and drug discovery
Enabling more accurate insights into disease pathogenesis
Microbiome-modulating antibody therapy for type 2 diabetes
Probiotic pills that protect against respiratory infections